Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.
Identifieur interne : 000469 ( Ncbi/Merge ); précédent : 000468; suivant : 000470Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.
Auteurs : Andrew C. Miller [États-Unis] ; Elamin M. Elamin ; Anthony F. SuffrediniSource :
- Critical care medicine [ 1530-0293 ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
- administration et posologie : Anticoagulants.
- traitement médicamenteux : Lésion par inhalation de fumée, Lésion pulmonaire aigüe.
- étiologie : Lésion pulmonaire aigüe.
- Administration par inhalation, Humains, Lésion par inhalation de fumée.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Anticoagulants.
- complications : Smoke Inhalation Injury.
- drug therapy : Acute Lung Injury, Smoke Inhalation Injury.
- etiology : Acute Lung Injury.
- Administration, Inhalation, Humans.
Abstract
Inhaled anticoagulation regimens are increasingly being used to manage smoke inhalation-associated acute lung injury. We systematically reviewed published and unpublished preclinical and clinical trial data to elucidate the effects of these regimens on lung injury severity, airway obstruction, ventilation, oxygenation, pulmonary infections, bleeding complications, and survival.
DOI: 10.1097/CCM.0b013e3182a645e5
PubMed: 24158173
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003B77
- to stream PubMed, to step Curation: 003B51
- to stream PubMed, to step Checkpoint: 003B51
Links to Exploration step
pubmed:24158173Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.</title><author><name sortKey="Miller, Andrew C" sort="Miller, Andrew C" uniqKey="Miller A" first="Andrew C" last="Miller">Andrew C. Miller</name><affiliation wicri:level="2"><nlm:affiliation>1Department of Critical Care Medicine, Clinical Center, National Institutes of Health, Bethesda, MD. 2Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh Medical Center, Pittsburgh, PA. 3Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, James A. Haley Veteran's Hospital and University of South Florida, Tampa, FL.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Floride</region></placeName><wicri:cityArea>1Department of Critical Care Medicine, Clinical Center, National Institutes of Health, Bethesda, MD. 2Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh Medical Center, Pittsburgh, PA. 3Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, James A. Haley Veteran's Hospital and University of South Florida, Tampa</wicri:cityArea></affiliation></author><author><name sortKey="Elamin, Elamin M" sort="Elamin, Elamin M" uniqKey="Elamin E" first="Elamin M" last="Elamin">Elamin M. Elamin</name></author><author><name sortKey="Suffredini, Anthony F" sort="Suffredini, Anthony F" uniqKey="Suffredini A" first="Anthony F" last="Suffredini">Anthony F. Suffredini</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24158173</idno><idno type="pmid">24158173</idno><idno type="doi">10.1097/CCM.0b013e3182a645e5</idno><idno type="wicri:Area/PubMed/Corpus">003B77</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003B77</idno><idno type="wicri:Area/PubMed/Curation">003B51</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003B51</idno><idno type="wicri:Area/PubMed/Checkpoint">003B51</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003B51</idno><idno type="wicri:Area/Ncbi/Merge">000469</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.</title><author><name sortKey="Miller, Andrew C" sort="Miller, Andrew C" uniqKey="Miller A" first="Andrew C" last="Miller">Andrew C. Miller</name><affiliation wicri:level="2"><nlm:affiliation>1Department of Critical Care Medicine, Clinical Center, National Institutes of Health, Bethesda, MD. 2Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh Medical Center, Pittsburgh, PA. 3Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, James A. Haley Veteran's Hospital and University of South Florida, Tampa, FL.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Floride</region></placeName><wicri:cityArea>1Department of Critical Care Medicine, Clinical Center, National Institutes of Health, Bethesda, MD. 2Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh Medical Center, Pittsburgh, PA. 3Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, James A. Haley Veteran's Hospital and University of South Florida, Tampa</wicri:cityArea></affiliation></author><author><name sortKey="Elamin, Elamin M" sort="Elamin, Elamin M" uniqKey="Elamin E" first="Elamin M" last="Elamin">Elamin M. Elamin</name></author><author><name sortKey="Suffredini, Anthony F" sort="Suffredini, Anthony F" uniqKey="Suffredini A" first="Anthony F" last="Suffredini">Anthony F. Suffredini</name></author></analytic><series><title level="j">Critical care medicine</title><idno type="eISSN">1530-0293</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Lung Injury (drug therapy)</term><term>Acute Lung Injury (etiology)</term><term>Administration, Inhalation</term><term>Anticoagulants (administration & dosage)</term><term>Humans</term><term>Smoke Inhalation Injury (complications)</term><term>Smoke Inhalation Injury (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par inhalation</term><term>Anticoagulants (administration et posologie)</term><term>Humains</term><term>Lésion par inhalation de fumée ()</term><term>Lésion par inhalation de fumée (traitement médicamenteux)</term><term>Lésion pulmonaire aigüe (traitement médicamenteux)</term><term>Lésion pulmonaire aigüe (étiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anticoagulants</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anticoagulants</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Smoke Inhalation Injury</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Acute Lung Injury</term><term>Smoke Inhalation Injury</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Acute Lung Injury</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lésion par inhalation de fumée</term><term>Lésion pulmonaire aigüe</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lésion pulmonaire aigüe</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Inhalation</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par inhalation</term><term>Humains</term><term>Lésion par inhalation de fumée</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Inhaled anticoagulation regimens are increasingly being used to manage smoke inhalation-associated acute lung injury. We systematically reviewed published and unpublished preclinical and clinical trial data to elucidate the effects of these regimens on lung injury severity, airway obstruction, ventilation, oxygenation, pulmonary infections, bleeding complications, and survival.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24158173</PMID><DateCreated><Year>2014</Year><Month>01</Month><Day>17</Day></DateCreated><DateCompleted><Year>2014</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit. Care Med.</ISOAbbreviation></Journal><ArticleTitle>Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.</ArticleTitle><Pagination><MedlinePgn>413-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0b013e3182a645e5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Inhaled anticoagulation regimens are increasingly being used to manage smoke inhalation-associated acute lung injury. We systematically reviewed published and unpublished preclinical and clinical trial data to elucidate the effects of these regimens on lung injury severity, airway obstruction, ventilation, oxygenation, pulmonary infections, bleeding complications, and survival.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">PubMed, Scopus, EMBASE, and Web of Science were searched to identify relevant published studies. Relevant unpublished studies were identified by searching the Australian and New Zealand Clinical Trials Registry, World Health Organization International Clinical Trials Registry Platform, Cochrane Library, ClinicalTrials.gov, MINDCULL.com, Current Controlled Trials, and Google.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Inclusion criteria were any preclinical or clinical study in which 1) animals or subjects experienced smoke inhalation exposure, 2) they were treated with nebulized or aerosolized anticoagulation regimens, including heparin, heparinoids, antithrombins, or fibrinolytics (e.g., tissue plasminogen activator), 3) a control and/or sham group was described for preclinical studies, and 4) a concurrent or historical control group described for clinical studies. Exclusion criteria were 1) the absence of a group treated with a nebulized or aerosolized anticoagulation regimen, 2) the absence of a control or sham group, and 3) case reports.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Ninety-nine potentially relevant references were identified. Twenty-seven references met inclusion criteria including 19 preclinical references reporting 18 studies and eight clinical references reporting five clinical studies.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">A systematic review of the literature is provided. Both clinical and methodological diversity precluded combining these studies in a meta-analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The high mortality associated with smoke inhalation-associated acute lung injury results from airway damage, mucosal dysfunction, neutrophil infiltration, airway coagulopathy with cast formation, ventilation-perfusion mismatching with shunt, and barotrauma. Inhaled anticoagulation regimens in both preclinical and clinical studies improve survival and decrease morbidity without altering systemic markers of clotting and anticoagulation. In some preclinical and clinical studies, inhaled anticoagulants were associated with a favorable effect on survival. This approach appears sufficiently promising to merit a well-designed prospective study to validate its use in patients with severe smoke inhalation-associated acute lung injury requiring mechanical ventilation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Andrew C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>1Department of Critical Care Medicine, Clinical Center, National Institutes of Health, Bethesda, MD. 2Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh Medical Center, Pittsburgh, PA. 3Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, James A. Haley Veteran's Hospital and University of South Florida, Tampa, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elamin</LastName><ForeName>Elamin M</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Suffredini</LastName><ForeName>Anthony F</ForeName><Initials>AF</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z99 CL999999</GrantID><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2014 Feb;42(2):474-5</RefSource><PMID Version="1">24434458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Pathol. 1982 Apr;13(4):355-64</RefSource><PMID Version="1">7076218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Burns. 2011 May;37(3):465-73</RefSource><PMID Version="1">21195551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Care Med. 2002 Mar;30(3):637-43</RefSource><PMID Version="1">11998809</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Burns. 2001 Jun;27(4):349-58</RefSource><PMID Version="1">11348743</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Burns. 2009 Sep;35(6):802-10</RefSource><PMID Version="1">19303716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pulm Pharmacol Ther. 2007;20(2):172-7</RefSource><PMID Version="1">16814583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Care Med. 2007 Dec;35(12):2805-10</RefSource><PMID Version="1">18074480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Plast Surg. 2009 Oct;36(4):555-67</RefSource><PMID Version="1">19793551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Plast Surg. 1974 Oct;1(4):693-703</RefSource><PMID Version="1">4609676</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Burns. 2010 Jun;36(4):506-10</RefSource><PMID Version="1">19857928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Trauma. 1991 Nov;31(11):1477-86</RefSource><PMID Version="1">1942167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicology. 1996 Dec 31;115(1-3):119-22</RefSource><PMID Version="1">9016745</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Sci (Lond). 2008 Feb;114(4):321-9</RefSource><PMID Version="1">17927568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 1990 Dec;212(6):720-7</RefSource><PMID Version="1">2256764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Physiol (1985). 1990 Nov;69(5):1734-9</RefSource><PMID Version="1">2272966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Emerg Med Clin North Am. 2003 May;21(2):533-57</RefSource><PMID Version="1">12793627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Burn Care Rehabil. 1988 Jan-Feb;9(1):22-5</RefSource><PMID Version="1">3356738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Shock. 2008 Mar;29(3):356-61</RefSource><PMID Version="1">17693942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Burn Care Res. 2008 Jan-Feb;29(1):192-5</RefSource><PMID Version="1">18182921</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 1993 Dec;166(6):592-6; discussion 596-7</RefSource><PMID Version="1">8273836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Burns. 1998 Nov;24(7):671-5</RefSource><PMID Version="1">9882069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 1987 Jan;205(1):82-7</RefSource><PMID Version="1">3800465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chest Med. 2002 Dec;23(4):707-15</RefSource><PMID Version="1">12512160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pulm Pharmacol Ther. 2007;20(2):163-6</RefSource><PMID Version="1">16798035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Burns. 2005 May;31(3):331-6</RefSource><PMID Version="1">15774289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pediatr Surg. 1994 Aug;29(8):1122-6</RefSource><PMID Version="1">7965518</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>News Physiol Sci. 2003 Jun;18:125-9</RefSource><PMID Version="1">12750450</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Cell Mol Biol. 2003 Sep;29(3 Pt 1):295-302</RefSource><PMID Version="1">12936906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Burns. 2011 Nov;37(7):1154-60</RefSource><PMID Version="1">21816542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Burn Care Rehabil. 1989 Jan-Feb;10(1):27-37</RefSource><PMID Version="1">2921256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1994 Sep 8;331(10):637-42</RefSource><PMID Version="1">7503821</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Paediatr Respir Rev. 2006 Jun;7(2):123-8</RefSource><PMID Version="1">16765298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Care Med. 2006 May;34(5):1428-36</RefSource><PMID Version="1">16540966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 1984 Feb 10;251(6):771-3</RefSource><PMID Version="1">6694281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Trauma. 1986 Feb;26(2):163-5</RefSource><PMID Version="1">3944839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Respir Med. 2009 Jun 1;3(3):283-297</RefSource><PMID Version="1">20161170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Respir Res. 2010;11:172</RefSource><PMID Version="1">21134294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Burn Care Rehabil. 1998 May-Jun;19(3):210-2</RefSource><PMID Version="1">9622463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Burn Care Res. 2009 Mar-Apr;30(2):249-56</RefSource><PMID Version="1">19165116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Emerg Med. 1988 Nov-Dec;6(6):471-3</RefSource><PMID Version="1">3221064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Mech Methods. 2010 Oct;20(8):504-9</RefSource><PMID Version="1">20843269</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D055371" MajorTopicYN="N">Acute Lung Injury</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015208" MajorTopicYN="N">Smoke Inhalation Injury</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">NIHMS518685</OtherID><OtherID Source="NLM">PMC3947059</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24158173</ArticleId><ArticleId IdType="doi">10.1097/CCM.0b013e3182a645e5</ArticleId><ArticleId IdType="pmc">PMC3947059</ArticleId><ArticleId IdType="mid">NIHMS518685</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Floride</li></region></list><tree><noCountry><name sortKey="Elamin, Elamin M" sort="Elamin, Elamin M" uniqKey="Elamin E" first="Elamin M" last="Elamin">Elamin M. Elamin</name><name sortKey="Suffredini, Anthony F" sort="Suffredini, Anthony F" uniqKey="Suffredini A" first="Anthony F" last="Suffredini">Anthony F. Suffredini</name></noCountry><country name="États-Unis"><region name="Floride"><name sortKey="Miller, Andrew C" sort="Miller, Andrew C" uniqKey="Miller A" first="Andrew C" last="Miller">Andrew C. Miller</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000469 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000469 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:24158173
|texte= Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:24158173" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |